Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?

BACKGROUND: Gonadotropin-releasing hormone (GnRH) agonist triggering plus 1,500 IU human chorionic gonadotropin (hCG) supplementation protocol was previously claimed effective in reducing the ovarian hyperstimulation syndrome (OHSS) incidence in high responders. METHODS: This retrospective study inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurbuz, Ali Sami, Deveer, Ruya, Kucuk, Mert, Ozcimen, Necati, Incesu, Dilek, Koseoglu, Sezen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817580/
https://www.ncbi.nlm.nih.gov/pubmed/27081426
http://dx.doi.org/10.14740/jocmr2500w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817580/
https://www.ncbi.nlm.nih.gov/pubmed/27081426
http://dx.doi.org/10.14740/jocmr2500w

Ejemplares similares